Persistent URL of this record https://hdl.handle.net/1887/3277547
Documents
-
- Download
- 122556453_publishedVersion_None
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Anti-GD2 based immunotherapy prevents late events in high-risk neuroblastoma patients over 18 months at diagnosis
- All authors
- Tas, M.L.; Dootjes, L.W.; Fiocco, M.; Krijger, R.R. de; Dierselhuis, M.P.; Eijkelenburg, N.K.A. van; Grotel, M. van; Kraal, K.C.J.M.; Peek, A.M.L.; Tytgat, G.A.M.; Noesel, M.M. van
- Date
- 2021-10-01
- Journal
- Cancers
- Volume
- 13
- Issue
- 19